vimarsana.com
Home
Live Updates
Aurinia Pharmaceuticals Announces NICE Recommendation of LUPKYNIS® (Voclosporin) For Adults with Active Lupus Nephritis : vimarsana.com
Aurinia Pharmaceuticals Announces NICE Recommendation of LUPKYNIS® (Voclosporin) For Adults with Active Lupus Nephritis
Aurinia Pharmaceuticals Inc. today announced that the National Institute for Health and Care Excellence has recommended LUPKYNIS® as an option for treating adults with active lupus nephritis ... | May 3, 2023
Related Keywords
Rockville ,
Maryland ,
United States ,
United Kingdom ,
Great Britain ,
Peter Greenleaf ,
Healthcare Products Regulatory Agency ,
Aurinia Pharmaceuticals Inc ,
National Institute For Health ,
Nasdaq ,
Aurinia Pharmaceuticals ,
National Institute ,
Care Excellence ,
Chief Executive Officer ,
European Commission Approved ,
Red Cell Aplasia ,
Drug Interactions ,
Moderate Hepatic Impairment ,
Prescribing Information ,
Boxed Warning ,
Medication Guide ,
Renal Response ,
Active Lupus With Voclosporin ,
Renal Assessments ,
Aurinia Renal Response ,
Lupus With Voclosporin ,
Aurinia Pharmaceuticals Inc Stock Exchange ,
News ,
Information ,
Press Release ,
Aurinia ,
Pharmaceuticals ,
Oday ,
Nnounced ,
Hat ,
The ,
Ational ,
Institute ,
Or ,
Health ,
End ,
Mare ,
Excellence ,
Gas ,
Ecommended ,
Us ,
N ,
Option ,
Reating ,
Adults ,
Ith ,
Ctive ,
Lupus ,
Ephritis Auph Ca05156v1022 ,
vimarsana.com © 2020. All Rights Reserved.